| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 216660 | NDA | AMYLYX | 001 | RELYVRIO | FOR SUSPENSION;ORAL | 3GM/PACKET; 1GM/PACKET | SODIUM PHENYLBUTYRATE; TAURURSODIOL | 2022-09-29 | Discontinued | No |